BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hu T, Yao L, Hu A, Jiang S, Ying H, Deng Q, Hu Y, Zhou W, Xiong T. Nucleos(t)ide analogs improve long-term prognosis in patients with chronic hepatitis B-associated liver failure: Nucleos(t)ide analogs improve prognosis. Hepatol Res 2017;47:347-58. [DOI: 10.1111/hepr.12755] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Nagaoki Y, Aikata H, Daijyo K, Teraoka Y, Honda F, Nakamura Y, Hatooka M, Morio K, Fujino H, Nakahara T, Kawaoka T, Miki D, Tsuge M, Hiramatsu A, Imamura M, Kawakami Y, Ochi H, Chayama K. Risk factors for exacerbation of gastroesophageal varices and portosystemic encephalopathy during treatment with nucleos(t)ide analogs for hepatitis B virus-related cirrhosis. Hepatol Res 2018;48:264-74. [PMID: 29114970 DOI: 10.1111/hepr.12996] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
2 Lei J, Zeng YL, Xu LY, Wang Y. Analysis of Treatment of 3 Patients with Acute-on-Chronic Liver Failure. Case Rep Med 2018;2018:7421502. [PMID: 30595700 DOI: 10.1155/2018/7421502] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Wang L, Wu Z, Wang A, Jin X, Qiu Y. Effects of nucleo(s)tide analogs therapy on chronic hepatitis B as evaluated by hepatosplenic radionuclide angiography. Nucl Med Commun 2020;41:314-9. [PMID: 31939901 DOI: 10.1097/MNM.0000000000001156] [Reference Citation Analysis]